Market Analysis - Asia Pacific Biotech Congress 2017
Why to attend?
This unique international conference provides a platform for researchers and decision makers in biotechnology to present and exchange their latest findings from all over the world and learn about all the important developments in the field of biotechnology. The conference will cover the novel strategies and translational nature of biotechnological research, with emphasis on both the basic science as well as its applications in industry and academia. Throughout the course of the three-day conference, you will have the opportunity to both network and hear world-renowned speakers from the international academic and corporate biotechnology communities. This is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your industry may offer to a broad international audience. It covers a wide range of topics including advancements in biotechnology, pharmaceutical biotechnology, medical biotechnology, industrial biotechnology, agriculture biotechnology, environmental biotechnology, bio-products and bioenergy.
Scope and Importance of Biotechnology
Biotechnology is a field of applied biology that involves the use of living organisms and bioprocesses in engineering, medicine, technology and other fields requiring bio-products. Modern use similar term includes genetic engineering as well as cell and tissue culture technologies. It is the integrated use of molecular biology, biochemistry and microbiology to achieve technological application of the capabilities of biological agents. Biotechnology is emerged as a science with immense potential for human welfare ranging from food processing, human health to environment protection. The field of biotechnology is constantly advancing. From finding ways to slow down the process of food spoilage, advancements in genetic engineering, to adapting organisms to clean up contaminated environments, new applications and biotechnological inventions are continuously being developed to help improve our world.
Modern biotechnology applies not only modern genetics but also advances in other sciences. However, there is a third revolution that is just emerging, which is nanotechnology. The development of techniques to visualize and manipulate atoms individually or in small clusters is opening the way to an ever-finer analysis of living systems. Nano-scale techniques are now beginning to play substantial role in the application of biotechnology.
World renowned experts and intellectuals agree that biotechnological innovation is the foundation-stone of our future, and a ‘game changer’. It is anticipated that it will underpin our economy and provide solutions to intractable problems of human and animal diseases, climate change, fuel alternatives, food security as well as improving our quality of life.
Biotechnology in Australia
The Australian biotechnology industry is one of the largest in the world. Despite the challenges of the global economy and the degree of difficulty in building a biotechnology and life sciences sector from scratch, Australia is doing very well by any comparative measure, with an impressive return on investment from a maturing stock of quality companies. Australian biotechnology boasts a raft of success stories and a world-class industry. Since its emergence in the early to mid-nineties, the biotechnology industry in Australia has achieved a great deal.
Australia’s comparative advantage comes from its world-class science and medical research, its capacity for international partnerships, cost effectiveness, and a transparent and effective regulatory system. Jobs of the future will be found in the biotech and pharmaceuticals sector, and the medical technology sector. In addition, there are many thousands of direct jobs in the agricultural and industrial biotechnology sectors and indirect jobs in dependent areas such as clinical trial teams, high-tech manufacturing, medical research and supplies to the medical technology sector and in services such as those provided by patent attorneys. Innovative industries provide high-skilled jobs with long-term prospects.
The Research & Development (R&D) Tax Incentive has been a long-established source of funding and support for businesses in the research, development and early developmental commercialization phases. The policy driver behind the R&D Tax Incentive is to encourage more companies to engage in R&D in Australia. And it’s working: a number of companies have publically stated that they have set up in Australia because of the support provided by the R&D Tax Incentive.
Australian state governments are developing and implementing independent regional initiatives. Each has strong medical research programs, some having specialist expertise in areas including tropical medicine, bio-discovery, regenerative medicine, bioremediation, agricultural/industrial biotech and medical devices. Australian life sciences companies have attracted well over $2 billion in deal flow over the last 18 months. Global recognition of the sector’s quality was reflected in major deals, including Novartis’ acquisition of Spinifex Pharmaceuticals for as much as AU$1 billion and AstraZeneca’s licensing agreement with Starpharma that could deliver over half a billion (AU) dollars.
Biotech Market in Asia Pacific
Biotechnology market in 2010, between US$400 billion and US$600 billion in revenue was generated by this medium also, it is anticipated that in 2015, this online market will generate revenue between US$700 billion and US$950 billion.
Middle East: Biotechnology market is currently its trade deficit is nearly US$8 billion, its external debt market is expected to grow to nearly US$31.6 billion during the forecast period 2016-2019.
Competitive Market Share
Major industry players are Abbott, Amgen, AstaZeneca, Biogen, Celgene, Genzyme, Johnson & Johnson, Pfizer, GlaxoSmithKline, Genentech, F. Hoffman La Roche, Novartis, Lonza and Sanofi.
Key strategies adopted by the companies to increase global biotechnology market share includes mergers and acquisitions, strategic collaborations, outsourcing R&D, and manufacturing activities. In 2015, Roche collaborated with Janus Biotherapeutics, a U.S. based Biotechnology Company to develop treatment for autoimmune disease, while Celgene acquired Quanticel, a biotechnology company to increase their focus on cancer drug discovery.
List of Major Universities in Melbourne and Australia
· Australian National University
· University of Queensland
· Charles Darwin University
· Curtin University
· Deakin University
· Flinders University
· Monash University
· RMIT University
· University of Adelaide
· University of Melbourne
· University of New South Wales
· University of South Australia
· University of Sydney
List of Major Biotechnology Associations/Societies around the World
· Australia Biotechnology Association (AusBiotech Ltd)
· New Zealand Biotechnology (NZBIO)
· American Society for Biochemistry and Molecular Biology
· American Society of Gene Therapy
· Biotechnology and Biological Sciences Research Council (BBSRC)
· European Association of Pharma Biotechnology (EAPB)
· European Federation of Biotechnology
Major Biotechnology Companies
· CSL, Australia
· Pfizer, Australia
· Novogen, Australia
· Advent Pharmaceuticals, Australia
· Merck, USA
· Johnson & Johnson, USA
· Novartis, Switzerland
· Bayer, Germany
· GlaxoSmithKline, UK